Advertisement

Reactions Weekly

, Volume 1739, Issue 1, pp 6–6 | Cite as

Anti-PD-1 antibodies: immune-related adverse events and efficacy

Clinical study
  • 17 Downloads

Reference

  1. Rogado J, et al. Immune-related adverse events predict the therapeutic efficacy of anti-PD-1 antibodies in cancer patients. European Journal of Cancer 109: 21-27, 22 Jan 2019. Available from: URL: http://doi.org/10.1016/j.ejca.2018.10.014 CrossRefPubMedGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Personalised recommendations